Partner with us

Partnering with MIND Foundation offers a unique opportunity to drive important research and implement innovative programs in mental health and human development. 

Our commitment to scientific rigor and ethical standards drives impactful solutions, making us a trusted leader in the field of psychedelic research and therapies. By collaborating with us, you contribute to pioneering studies and join a network dedicated to enhancing mental health care across Europe and beyond. Together, we can transform lives, influence public health policies, and shape the future of mental wellness. 

Join us in making a meaningful difference through research, education, and community engagement.



In the MIND Foundation, we distinguish between two general kinds of partnerships which we may develop further into different sub-types. 

  1. Cooperations are a type of partnership where actual resources flow in via money, personnel, or materials. In this case, an entire corresponding contract is necessary for tax reasons and clarifying characteristics like a partner’s non-profit or for-profit status. In cooperation projects, it is also important to specify, for example, the publication rights. For cooperation contracts, we usually use templates available by the European or German Research Council and adapt them. 
  2. The second type of partnerships are resource-free collaborations (there is no flow of material resources, but of course time itself is a very important resource) and are usually about the joint implementation of a project or mutual provided services like media cooperations. Here, a contract is not mandatory, but can always be useful to build clarity and avoid controversies – as these here and there occur e.g. in joint publications.

OVID Clinic Berlin

OVID Clinic Berlin is Europe’s first mental health provider integrating psychedelic therapies into a guideline-based outpatient and day clinic model. Founded in 2021, OVID is a cornerstone of the MIND Foundation ecosystem. While it operates as an independent entity, OVID closely aligns with MIND’s mission and values. 

OVID Clinic Berlin targets diverse patient needs and groups with guideline therapies and psychedelic treatments. Our collaboration ensures that our patients benefit from the latest scientific advancements in psychedelic therapies, while adhering to the highest standards of clinical practice. 

Together, MIND and OVID are transforming the landscape of mental health care, paving the way for more effective, accessible, and holistic treatment options.

EPIsoDE Study Partners

Along with the Central Institute of Mental Health in Mannheim and the Department of Psychiatry and Psychotherapy at Charité Universitätsmedizin Berlin, we are a partner in what is currently the largest science-initiated psilocybin study in the world. The study is funded by the German Federal Ministry of Education and Research (BMBF). 

This phase 2b clinical trial is called EPIsoDE. It is investigating the safety and efficacy of psilocybin in the treatment of patients with treatment-resistant depression. There are two centers in Mannheim and Berlin. 

Data readout expected in Q3 2024.

Conference Collaborations

Subscribe to our Newsletter

MIND Newsletter